FEDERATED HERMES, INC. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2023$14,174
+1123.0%
2,747
+1148.6%
0.00%
Q1 2023$1,159
+14.3%
220
-39.1%
0.00%
Q4 2022$1,014
-100.0%
361
-100.0%
0.00%
-100.0%
Q3 2022$3,327,000
-30.6%
801,736
-32.7%
0.01%
-23.1%
Q2 2022$4,792,000
+55.6%
1,192,072
+91.6%
0.01%
+85.7%
Q1 2022$3,080,000
-40.1%
622,280
+98.7%
0.01%
-30.0%
Q1 2021$5,140,000
-0.2%
313,238
+25.8%
0.01%
-9.1%
Q4 2020$5,152,000
+257500.0%
248,911
+118996.2%
0.01%
Q3 2020$2,000
+100.0%
209
+1800.0%
0.00%
Q1 2018$1,0000.0%11
-90.9%
0.00%
Q4 2017$1,0000.0%1210.0%0.00%
Q3 2017$1,000
-50.0%
121
-54.2%
0.00%
Q2 2017$2,000
-99.9%
264
-99.9%
0.00%
-100.0%
Q3 2016$1,798,000
-74.0%
261,700
-81.3%
0.01%
-75.0%
Q2 2016$6,912,000
-56.6%
1,396,287
-15.2%
0.02%
-59.2%
Q1 2016$15,912,000
+3.1%
1,647,2330.0%0.05%0.0%
Q4 2015$15,435,000
-36.1%
1,647,233
-4.1%
0.05%
-37.2%
Q3 2015$24,162,000
-15.5%
1,718,480
+26.4%
0.08%
-9.3%
Q2 2015$28,594,000
+199.0%
1,359,700
+496.9%
0.09%
+196.6%
Q1 2015$9,564,000
+16.2%
227,800
-34.9%
0.03%
+16.0%
Q4 2014$8,232,000
+57.1%
350,0000.0%0.02%
+47.1%
Q3 2014$5,240,000350,0000.02%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,932,607$40,643,00015.56%
Lamond Capital Partners LLC 711,533$14,964,00015.19%
Polaris Venture Management Co. V, L.L.C. 1,230,009$25,867,00011.54%
NOTTINGHAM ADVISORS, INC. 171,985$3,617,0000.60%
Portolan Capital Management 122,518$2,577,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 160,000$3,365,0000.33%
Rotella Capital Management, Inc. 18,461$388,0000.32%
Monashee Investment Management LLC 28,834$606,0000.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 335,498$7,056,0000.24%
BAILARD, INC. 55,000$1,157,0000.18%
View complete list of OCULAR THERAPEUTIX INC shareholders